Page 11 - Trial Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Delcath Systems (NASDAQ:DCTH – Get Free Report) and Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Earnings & Valuation This table compares Delcath […]

Atrion (NASDAQ:ATRI – Get Free Report) and Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership. Institutional and Insider Ownership 66.2% of Atrion shares […]

As you might have guessed from the title of this blog post, the theme for this year’s conference is ALL IN. It makes perfect sense because, as the conference website says, “get ready to...

The National Cancer Institute announced a new program to study HPV testing via self-collection to prevent cervical cancer. Cancer experts Drs. Brian Slomovitz and Nicole Saphier discuss this method.

A push for more accessible HPV testing is underway. A new program called SHIP Trial Network, led by the National Cancer Institute (NCI), is exploring testing for human papillomavirus (HPV) via self-collection to prevent cervical cancer, according to a press release. The Last Mile Initiative, announced at the White House Cervical Cancer Forum on Jan.